There's only been one official clinical trial testing BPC 157 in humans, and it was cancelled. The other safety data we have comes from tiny, unpublished studies that aren't reliable enough to prove this peptide is safe or works as a medicine.

Evidence from Studies

Supporting (0)

0

Community contributions welcome

No supporting evidence found

Contradicting (1)

0

Community contributions welcome

0

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”

Editorial/Opinion

2025 Sep 28

This study is a letter about how BPC 157 might work in the body (its mechanisms), not a study testing whether it's safe or effective in actual patients. The claim is about a specific clinical trial being cancelled and lacking good safety data - this reply letter doesn't address those specific points.

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”

0

DOI: 10.3390/ph18101451

Similar Assertions

BPC-157 is a healing peptide that's mostly been researched by one small group of scientists. Usually, when a drug really works, lots of different scientists all over the world start studying it right away.

0

70%